Author: Dr Val Phua
Estimated reading time: 18 minutes
No currently established eye drop can cure or remove an ordinary age-related cataract.
A cataract is a structural change inside the eye’s natural crystalline lens. As lens proteins and fibres become damaged, cloudy, yellowed or irregular, they scatter light rather than focusing it clearly onto the retina.
Artificial tears, anti-inflammatory drops and other eye medications may improve accompanying eye conditions. They do not restore an established cataractous lens to its original transparency.
As of July 2026, the US Food and Drug Administration states that there are no over-the-counter treatments for cataracts and advises consumers not to use products marketed for this purpose. The National Eye Institute similarly states that surgery is the only established way to remove a cataract.
The most accurate answer is:
Eye drops do not currently cure ordinary human cataracts. Some drops treat other eye conditions or support cataract-surgery recovery, while experimental cataract-dissolving compounds remain under investigation.
What Is a Cataract?
A cataract is clouding or increasing optical irregularity within the eye’s natural crystalline lens.
The lens lies behind the coloured iris and normally helps focus light onto the retina. A healthy lens must remain:
- Transparent
- Smooth
- Precisely organised
- Chemically stable
- Able to transmit light with minimal scatter
A cataract may cause:
- Gradual blurred or hazy vision
- Glare from headlights or sunlight
- Halos around lights
- Poor night vision
- Faded or yellowed colours
- Reduced contrast
- Frequent spectacle-prescription changes
- Increasing short-sightedness
- Monocular ghosting or double vision
Cataracts are diagnosed during an eye examination. Surgery is generally considered when the resulting visual impairment interferes with activities such as driving, reading, work, mobility or independence.
What Would It Mean for an Eye Drop to Cure a Cataract?
A true cataract-curing drop would need to produce measurable and lasting improvement in the natural lens itself.
It would need to:
- Reach the lens in an effective concentration
- Reverse or prevent abnormal protein aggregation
- Restore lens-fibre organisation
- Reduce lens opacity
- Improve light transmission
- Improve glare and contrast
- Improve visual function
- Remain safe for the cornea, eye pressure, retina and optic nerve
- Produce reliable results across a meaningful number of patients
A patient feeling that their vision is better does not necessarily prove that the cataract has cleared.
Vision may temporarily improve because:
- Dry eye was treated
- The spectacle prescription was updated
- Blood glucose became more stable
- The pupil changed size
- Better lighting was used
- The other eye compensated
- Inflammation was reduced
These improvements can occur while the cataract itself remains unchanged.
Why Is It Difficult for Eye Drops to Treat a Cataract?
The natural lens is not located on the surface of the eye.
A topical medication must pass through several biological barriers before it can affect the lens.
The drop must:
- Remain sterile and chemically stable inside the bottle.
- Stay on the eye despite blinking and tear drainage.
- Penetrate the corneal epithelium.
- Cross the deeper corneal layers.
- Enter the aqueous humour inside the eye.
- Remain active at a safe concentration.
- Cross the lens capsule.
- Reach the relevant layer within the lens.
- Reverse decades of accumulated structural damage.
- Avoid toxic effects on other ocular tissues.
Only a small proportion of many topical medications reaches the inside of the eye. Poor solubility, rapid tear drainage, short contact time and limited penetration are major challenges in developing non-surgical cataract treatments. Reviews of cataract pharmacotherapy identify drug delivery into the lens as one of the principal barriers to clinical treatment.
Why Do Cataracts Not Simply Dissolve?
The natural lens contains highly concentrated structural proteins called crystallins.
These proteins must remain properly folded and organised for many decades. With ageing and other forms of stress, they may undergo:
- Oxidation
- Cross-linking
- Glycation
- Truncation
- Loss of solubility
- Misfolding
- Aggregation
Lens fibres may also develop abnormalities involving:
- Water balance
- Electrolyte movement
- Cell membranes
- Intercellular communication
- Antioxidant protection
Once these changes become structurally established, an ordinary lubricant or antioxidant drop cannot simply wash the damaged material away.
The central lens has little ability to remove and replace old fibre cells or proteins. This makes reversing a mature cataract fundamentally different from treating temporary surface dryness or inflammation. Current reviews continue to describe cataract surgery—not pharmacological dissolution—as the established treatment for visually significant cataracts.
Are Any Cataract-Curing Eye Drops Approved?
There is no routinely established over-the-counter or prescription eye drop that has been shown to cure ordinary age-related cataracts in standard human clinical practice.
The FDA specifically warns consumers not to use OTC products marketed to treat serious eye conditions such as cataracts, glaucoma, retinopathy or macular degeneration because there are no OTC treatments for these conditions. The FDA also warns that unapproved products may contain ingredients unsuitable for use in the eye and that contaminated eye drops have caused infection, vision loss and blindness.
This does not mean that research has stopped.
Several compounds are being studied, but promising laboratory results are not equivalent to:
- Regulatory approval
- Proven clinical effectiveness
- Established dosing
- Long-term safety
- A replacement for cataract surgery
Why Do Some Products Claim to Dissolve Cataracts?
Commercial cataract drops may be marketed using claims such as:
- “Clinically tested”
- “Natural cataract reversal”
- “Protein-dissolving technology”
- “Scientifically developed”
- “Antioxidant lens repair”
- “Avoid cataract surgery”
- “Results within weeks”
These claims may be based on:
- Laboratory experiments
- Animal studies
- Small human studies
- Uncontrolled observations
- Research funded by the manufacturer
- Improvement in symptoms rather than lens clarity
- Testimonials
- Studies that were not independently reproduced
The phrase clinically tested does not mean the treatment was proven effective in a high-quality clinical trial.
Reliable evidence would ideally require:
- Randomisation
- A placebo or appropriate comparison group
- Masked examination
- Adequate patient numbers
- Validated cataract grading
- Objective lens imaging
- Visual-acuity and glare outcomes
- Independent replication
- Long-term safety data
What Is N-Acetylcarnosine?
N-acetylcarnosine, commonly abbreviated NAC, is an antioxidant-related compound marketed in some eye-drop products.
It is not the same substance as N-acetylcysteine, which is also sometimes abbreviated NAC.
The theory is that N-acetylcarnosine may penetrate the cornea and be converted into carnosine, which could potentially reduce oxidative damage within the lens.
An early study reported improvements in visual acuity, glare sensitivity and selected lens-image measurements among treated eyes.
However, these findings have not been confirmed sufficiently by independent, high-quality trials.
A Cochrane systematic review concluded that there was no convincing evidence that N-acetylcarnosine reverses cataracts or prevents cataract progression.
Why Is the Evidence for N-Acetylcarnosine Considered Weak?
Concerns include:
- Small study populations
- Incomplete or unclear trial methods
- High dropout rates
- Limited independent replication
- Uncertainty about masking
- Potential financial conflicts
- Reliance on subjective or variable outcomes
- Limited long-term safety information
An improvement in glare or measured visual acuity could also result partly from:
- Lubrication of the ocular surface
- Measurement variability
- Changes in refraction
- Regression to the mean
- Patient expectation
A reliable cataract treatment must demonstrate objective and sustained improvement in lens transparency—not only improvement in symptoms.
Should Patients Use N-Acetylcarnosine Drops?
Patients should not rely on N-acetylcarnosine as a replacement for indicated cataract surgery.
Using such a product may create several problems:
- Surgery may be delayed despite unsafe vision
- Driving difficulty may continue
- Another eye disease may be missed
- The product’s sterility or formulation may be uncertain
- The patient may spend substantial money without proven benefit
A patient already using these drops should tell their ophthalmologist and bring the packaging or ingredient list to the appointment.
What Is Lanosterol?
Lanosterol is a naturally occurring molecule involved in sterol synthesis.
Interest in lanosterol increased after a 2015 study reported that it reduced crystallin protein aggregation and improved transparency in:
- Laboratory protein experiments
- Isolated rabbit lenses
- Dogs with cataracts
The investigators proposed that lanosterol might represent a new strategy for cataract prevention or treatment.
These findings received extensive public attention and led to commercial products claiming to dissolve cataracts.
Do Lanosterol Drops Cure Human Cataracts?
This has not been demonstrated.
Important limitations include:
- The original findings were not based on a large human clinical trial.
- Human age-related cataracts are structurally complex.
- Lanosterol has limited solubility and ocular penetration.
- Effective delivery into the lens remains difficult.
- Later experiments did not consistently reproduce cataract reversal.
A subsequent investigation reported that lanosterol and related oxysterols failed to restore clarity or stop progression in several experimental cataract models.
Other research involving early cortical cataracts in primates has reported short-term reduction in cataract severity, showing that the biological question remains active. This still does not establish lanosterol drops as an effective human treatment.
The correct interpretation is:
Lanosterol is a research compound with conflicting preclinical findings—not an established human cataract cure.
What Is VP1-001?
VP1-001 is an oxysterol compound, also described in some research as related to 25-hydroxycholesterol.
It has been studied for its possible ability to interact with crystallin proteins and improve lens transparency.
Mouse studies have reported improvement in lens transparency or refractive-index profiles in selected lenses containing cataract-associated crystallin mutations. One 2022 study reported improvement in refractive-index profiles in 61% of treated mutant mouse lenses.
These are important mechanistic findings, but they do not prove that VP1-001 can safely cure ordinary human age-related cataracts.
Further work would need to establish:
- Human dosing
- Effective delivery
- Which cataract types might respond
- Magnitude of visual improvement
- Duration of benefit
- Ocular and systemic safety
- Comparison with observation or surgery
Are Other Cataract Drugs Being Studied?
Yes.
Researchers have investigated compounds intended to target:
- Oxidative stress
- Protein aggregation
- Lens-cell metabolism
- Abnormal calcium regulation
- Glycation
- Inflammation
- Membrane dysfunction
- Crystallin stability
Potential or experimental substances discussed in the literature include:
- N-acetylcysteine amide
- Myo-inositol
- Metformin
- Resveratrol
- Curcumin
- Alpha-lipoic acid
- Aldose-reductase inhibitors
- Oxysterols
- Molecular chaperones
- Nanoparticle drug-delivery systems
- Gene- or RNA-based treatments
Most remain at the:
- Laboratory stage
- Animal-study stage
- Early preclinical stage
- Formulation-development stage
Reviews published in 2023 and 2025 describe substantial scientific activity but continue to regard effective non-surgical cataract therapy as an unmet goal rather than an established clinical reality.
Could Cataract Eye Drops Become Available in the Future?
Possibly.
A future medication might not need to dissolve a mature cataract completely to be useful.
A successful treatment could potentially:
- Delay cataract onset
- Slow early progression
- Stabilise crystallin proteins
- Reduce oxidative injury
- Postpone surgery
- Help patients without access to surgery
- Treat selected genetic or metabolic cataracts
However, several questions remain:
- Can enough medication reach the lens?
- Which cataract type would respond?
- Would the effect be clinically meaningful?
- Would treatment need to continue indefinitely?
- Could the medication damage other ocular structures?
- Would delaying surgery improve or worsen long-term outcomes?
- Would the cost be reasonable?
Until properly conducted human trials demonstrate meaningful benefit and acceptable safety, experimental cataract drops should not be presented as proven treatment.
Can Artificial Tears Improve Cataract Vision?
Artificial tears do not remove cataracts.
They can improve vision when dry eye is contributing to blur.
The tear film forms the first optical surface of the eye. When it becomes unstable, patients may experience:
- Fluctuating vision
- Burning
- Grittiness
- Watering
- Glare
- Vision that clears after blinking
A patient may have both dry eye and cataract.
Treating dry eye may make the vision clearer and the cataract measurements more reliable, but the natural lens remains cloudy.
This distinction is especially important before:
- Deciding whether surgery is needed
- Measuring the eye for an intraocular lens
- Assessing the cause of fluctuating vision
- Selecting a premium lens
Can Glaucoma Drops Treat a Cataract?
No.
Glaucoma drops reduce eye pressure through mechanisms involving fluid production or drainage.
They are intended to protect the optic nerve.
They do not clear the natural lens.
A patient may have both glaucoma and cataract. Treating one condition does not automatically treat the other.
Cataract surgery may sometimes deepen the anterior chamber or contribute to lowering eye pressure, but this is a separate effect from glaucoma medication.
Can Steroid Drops Clear Cataracts?
No.
Steroid eye drops reduce inflammation.
They may be prescribed for:
- Uveitis
- Postoperative inflammation
- Corneal inflammation
- Other inflammatory eye conditions
They do not remove cataracts.
Long-term or repeated corticosteroid exposure can itself increase the risk of posterior subcapsular cataract in susceptible patients.
Steroids should not be stopped suddenly when they are medically necessary. The prescribing doctor should balance:
- Control of inflammation
- Cataract risk
- Eye-pressure risk
- The underlying disease
Can Anti-Inflammatory Drops Improve Cataract Symptoms?
They may improve accompanying inflammation but do not clear the lens.
For example, a patient with uveitis and cataract may have blurred vision from both:
- Active inflammation
- Lens clouding
Anti-inflammatory drops may improve the inflammatory component.
Once inflammation is controlled, the remaining cataract-related blur may still require surgery.
Why Are Drops Used Before Cataract Surgery?
Several types of drops may be used before surgery.
Dilating Drops
These enlarge the pupil so the surgeon can access and remove the cataract safely.
Anaesthetic Drops
These numb the ocular surface.
Antibiotic Drops
Some surgeons prescribe antibiotic drops before or after surgery, although infection-prevention protocols vary.
Non-Steroidal Anti-Inflammatory Drops
These may reduce postoperative inflammation, discomfort or macular-oedema risk in selected patients.
None of these medications dissolves the cataract.
They prepare the eye or reduce surgical complications.
Why Are Drops Used After Cataract Surgery?
After surgery, drops may be prescribed to:
- Reduce inflammation
- Prevent or treat infection
- Control eye pressure
- Relieve discomfort
- Support ocular-surface healing
- Reduce macular-oedema risk
Examples include:
- Steroid drops
- Non-steroidal anti-inflammatory drops
- Antibiotic drops
- Lubricants
- Pressure-lowering drops
FDA-approved ophthalmic anti-inflammatory medications may specifically be indicated for pain and inflammation following cataract surgery. Their purpose is postoperative care—not cataract dissolution.
Can Postoperative Drops Make the Cataract Come Back?
The original cataract cannot return because the cloudy natural lens has been removed.
Months or years after surgery, the back of the retained lens capsule may become cloudy.
This is called:
- Posterior capsule opacification
- PCO
- Secondary cataract
- After-cataract
PCO is not caused by failing to use enough lubricants or postoperative drops.
Can Eye Drops Treat Posterior Capsule Opacification?
No established eye drop reliably removes posterior capsule opacification.
PCO is usually treated with a YAG laser capsulotomy.
The laser creates an opening in the cloudy posterior capsule so that light can once again pass clearly through the visual axis.
The artificial intraocular lens is not removed during a routine YAG procedure.
Can Dilating Drops Temporarily Improve Vision Through a Cataract?
Occasionally, changing the pupil size may alter how light passes through a localised lens opacity.
For example:
- A larger pupil may allow light to pass around a small central opacity.
- A smaller pupil may reduce certain aberrations or glare.
- The effect may vary with cataract position.
This is not cataract reversal.
Pupil-modifying medication may also cause:
- Blurred near vision
- Light sensitivity
- Headache
- Eye-pressure changes
- Retinal symptoms in susceptible patients
It should not be used as routine home treatment for cataract without ophthalmic supervision.
Can Cataract Drops Improve Vision by Treating Dry Eye?
A product marketed as a cataract drop may contain lubricating ingredients.
If the patient also has dry eye, the drop may improve:
- Surface comfort
- Fluctuating vision
- Glare caused by tear-film instability
This may create the impression that the cataract has improved.
Objective examination may show that:
- The corneal surface is better
- The lens opacity is unchanged
- The visual improvement is temporary
A genuine cataract claim should be supported by documented improvement in lens opacity, not merely a short-lived improvement after instilling a lubricant.
Can Eye Drops Slow Cataract Progression?
No routine eye drop has been convincingly shown to slow ordinary age-related cataract progression in humans.
Some experimental studies suggest potential effects on:
- Oxidative stress
- Protein solubility
- Crystallin aggregation
- Lens metabolism
However, evidence from laboratory or animal studies cannot be assumed to apply to typical human cataracts.
Cataract progression also varies naturally. A cataract may remain stable for years even without treatment.
Without a properly controlled trial, natural stability may be incorrectly attributed to a commercial eye drop.
Can Vitamin Eye Drops Prevent Cataracts?
There is no established evidence that vitamin-containing eye drops prevent ordinary cataracts.
Potential problems include:
- Poor penetration into the lens
- Uncertain formulation
- Lack of controlled human trials
- Unproven dosing
- Questions about sterility
- Misleading marketing
A vitamin may have a recognised biological role without functioning as an effective topical treatment.
Do Oral Vitamins Work Better Than Cataract Drops?
No oral vitamin or supplement has been shown to reverse an established age-related cataract.
Randomised trials of antioxidant supplementation have not demonstrated convincing prevention or reversal of ordinary cataracts.
A balanced diet remains sensible for general health, but supplements should not be marketed as a substitute for surgery.
Can Diabetes-Related Cataracts Improve With Eye Drops?
Ordinary established diabetic cataracts do not disappear with eye drops.
A patient with diabetes may have blurred vision because of:
- Blood-glucose fluctuation
- Cataract
- Diabetic retinopathy
- Macular oedema
- Dry eye
- Glaucoma
Stabilising glucose may improve temporary refractive fluctuation. Treating macular oedema may improve retinal vision. Artificial tears may improve surface blur.
None of these necessarily removes the cataract.
Rare transient lens opacities may improve when a specific metabolic abnormality is corrected, but these unusual cases should not be generalised to ordinary diabetic cataracts.
Can Childhood Cataracts Be Treated With Drops?
A small peripheral childhood cataract may sometimes be monitored.
Selected partial opacities may be managed temporarily using:
- Spectacles
- Contact lenses
- Amblyopia treatment
- Pupil-modifying medication under specialist supervision
A dense central cataract blocking visual development generally cannot be cured with drops.
Delaying treatment may lead to deprivation amblyopia because the developing brain does not receive a clear image.
The decision depends on:
- The child’s age
- Cataract size
- Cataract location
- One-eye or two-eye involvement
- Visual behaviour
- Risk of amblyopia
Can Metabolic Cataracts Be Reversible?
Certain uncommon early metabolic lens changes may improve when the underlying biochemical problem is corrected promptly.
Examples include selected cataracts associated with disorders of galactose metabolism.
In these situations, the principal treatment is correction of the systemic metabolic disorder—not an ordinary cataract eye drop.
Once permanent structural lens damage has developed, surgery may still be necessary.
Can Animal Cataract Drops Be Used in Humans?
No.
A product sold for dogs or other animals should not be used in human eyes unless it has been specifically evaluated and approved for human use.
Animal and human eyes differ in:
- Cataract type
- Drug penetration
- Dose
- formulation
- Preservatives
- Safety testing
- Manufacturing requirements
The FDA has taken enforcement action against companies marketing unapproved lanosterol products with claims of curing animal cataracts.
A veterinary claim is not proof of human effectiveness.
Are “Natural” Cataract Drops Safer?
Not necessarily.
Natural substances can still be:
- Irritating
- Toxic
- Contaminated
- Allergenic
- Chemically unstable
- Unsuitable for the eye
Products containing household or non-ophthalmic ingredients may cause corneal damage or infection.
The FDA warns that some unapproved eye products contain substances inappropriate for use in the eye, including silver compounds, MSM, honey and CBD. It also notes that eye products bypass some of the body’s natural defences and therefore require sterility.
What Are the Risks of Unapproved Cataract Drops?
Possible risks include:
- Burning or irritation
- Allergic reaction
- Corneal abrasion
- Chemical injury
- Infection
- Contamination
- Scarring
- Raised eye pressure
- Interaction with prescribed medication
- Delay in treating another eye disease
- Delay in cataract surgery
- Permanent vision loss
A patient should stop using an eye product and seek assessment if it causes:
- Pain
- Redness
- Discharge
- Light sensitivity
- Reduced vision
- Eyelid swelling
How Can Patients Assess a Cataract-Drop Claim?
Ask the following questions.
Is It Approved for Treating Human Cataracts?
A product being available online does not mean it is approved.
Was It Tested in Humans?
Animal or laboratory findings are not enough.
Was the Study Randomised and Masked?
Without appropriate controls, natural variation and patient expectation can influence results.
Was Lens Clarity Measured Objectively?
Relevant measures may include:
- Standardised slit-lamp photography
- Scheimpflug densitometry
- Validated cataract-grading systems
- Objective scatter measurements
Were Visual Outcomes Measured?
A meaningful study should assess:
- Best-corrected visual acuity
- Glare
- Contrast sensitivity
- Daily visual function
Was the Study Independently Replicated?
One small study—particularly one linked to the manufacturer—is not definitive.
Were Adverse Effects Reported?
Claims of “no side effects” should create concern when long-term safety testing is absent.
Does the Company Promise to Avoid Surgery Completely?
No responsible treatment can guarantee that every cataract patient will avoid surgery.
What Can Be Done While Monitoring a Cataract?
When cataract symptoms remain mild, reasonable measures include:
- Updating spectacles
- Improving reading light
- Increasing text size
- Using magnification
- Wearing sunglasses for glare
- Treating dry eye
- Controlling diabetes
- Avoiding smoking
- Protecting the eyes from injury
- Attending scheduled examinations
- Avoiding night driving when vision feels unsafe
These measures may improve function or reduce additional risk.
They do not remove the cataract.
When Should Cataract Surgery Be Considered?
Surgery is generally considered when cataract-related vision interferes with:
- Driving
- Night driving
- Reading
- Computer use
- Employment
- Sports
- Cooking
- Walking safely
- Recognising faces
- Medication management
- Independence
- Quality of life
The cataract does not need to become “ripe.”
A modern review concluded that surgery reverses cataract-related visual impairment and prevents progressive cataract-related vision loss.
What Happens During Cataract Surgery?
During cataract surgery:
- The eye is numbed.
- Small incisions are created.
- The cloudy lens is divided and removed.
- Most of the capsular bag is preserved.
- A clear artificial intraocular lens is inserted.
- The incision usually seals without stitches.
The operation treats the cataract by removing the cloudy lens rather than attempting to chemically repair it.
Is Surgery Always Needed Immediately?
No.
Observation is often appropriate when:
- Symptoms are mild
- Updated glasses provide satisfactory vision
- Driving remains safe
- Daily activities are not significantly affected
- The retina can still be examined
- The cataract is stable
Surgery becomes more appropriate when the expected improvement outweighs the risks and the cataract is meaningfully affecting function.
Can Someone Use Cataract Drops While Waiting for Surgery?
There is generally no proven reason to use an unapproved cataract-dissolving product while waiting.
Patients should continue any prescribed drops used for legitimate conditions such as:
- Glaucoma
- Dry eye
- Allergy
- Uveitis
- Infection
- Postoperative care
They should tell their surgeon about every eye product and supplement they use.
Unapproved drops may need to be stopped if they:
- Irritate the surface
- Alter measurements
- Contain unknown ingredients
- Increase infection risk
When Should You Arrange an Eye Examination?
Arrange an assessment for:
- Gradual blurred or hazy vision
- Increasing glare
- Halos
- Poor night driving
- Faded colours
- Frequent spectacle changes
- Increasing myopia
- Monocular ghosting
- One eye becoming worse
- Glasses no longer restoring comfortable vision
An eye examination is important because these symptoms may also result from:
- Dry eye
- Corneal disease
- Glaucoma
- Macular degeneration
- Diabetic retinal disease
- Optic nerve disease
When Is Urgent Assessment Required?
Ordinary cataracts usually cause gradual, painless visual change.
Seek urgent assessment for:
- Sudden loss of vision
- Severe eye pain
- Marked redness
- Significant discharge
- A white corneal spot
- Sudden coloured halos with headache or nausea
- New flashes
- A sudden shower of floaters
- A curtain-like shadow
- Sudden distortion
- Eye trauma
- Symptoms following use of an unapproved eye product
These findings are not typical of an uncomplicated cataract.
Frequently Asked Questions
Do Any Eye Drops Cure Cataracts?
No established eye drop currently cures ordinary age-related cataracts.
Are Cataract Drops Available Without a Prescription?
Products are sold online, but availability does not establish safety or effectiveness.
The FDA states that there are no OTC treatments for cataracts.
Can Artificial Tears Clear Cataracts?
No.
They may improve dry-eye-related blur but do not clear the natural lens.
Can Cataract Drops Improve Vision?
A lubricant may temporarily improve the tear film.
This does not prove that the cataract has improved.
Can Eye Drops Stop Cataracts From Growing?
No routine eye drop has been convincingly shown to prevent progression of ordinary human age-related cataracts.
Do N-Acetylcarnosine Drops Work?
The evidence is not convincing.
A Cochrane review found no convincing evidence that they reverse cataract or prevent progression.
Do Lanosterol Drops Work?
Lanosterol has produced promising but conflicting laboratory and animal findings.
Human cataract cure has not been established.
What Is VP1-001?
It is an experimental oxysterol that has improved lens transparency in selected mouse cataract models.
It is not an established human cataract treatment.
Can Vitamin Drops Reverse Cataracts?
No.
No vitamin eye drop has been shown to restore established human cataracts reliably.
Can Herbal Drops Cure Cataracts?
No herbal preparation has been proven to cure ordinary cataracts.
Can Honey Treat Cataracts?
No.
Honey can irritate the eye and may be unsafe when not prepared as a sterile ophthalmic product.
Can Castor Oil Treat Cataracts?
No.
Castor oil does not dissolve the cloudy natural lens.
Do Steroid Drops Remove Cataracts?
No.
Steroids treat inflammation and may contribute to cataract development when used for prolonged periods.
Do Glaucoma Drops Remove Cataracts?
No.
They lower eye pressure but do not clear the lens.
Why Are Drops Used for Cataract Surgery?
They dilate or numb the eye, reduce inflammation, help prevent infection or support healing.
They do not dissolve the cataract.
Can Drops Treat Secondary Cataract?
No established drop removes posterior capsule opacification.
It is usually treated with YAG laser capsulotomy.
Can Cataracts Be Treated Without Surgery?
Mild symptoms may temporarily be managed with spectacles, lighting and visual aids.
These measures do not remove the cataract.
Is Cataract Surgery the Only Proven Cure?
Surgery is currently the only established treatment that removes an ordinary visually significant cataract.
Must the Cataract Become Ripe Before Surgery?
No.
Surgery is timed according to symptoms, function, eye health and patient needs.
Can Cataracts Return After Surgery?
The removed natural cataract cannot return.
Posterior capsule opacification may later cause cloudy vision.
Key Takeaway
Eye drops do not currently cure ordinary age-related cataracts.
Some drops may treat conditions occurring alongside cataracts:
- Artificial tears treat dry eye
- Glaucoma drops reduce eye pressure
- Steroid drops reduce inflammation
- Antibiotic drops treat or help prevent infection
- Anti-inflammatory drops support surgical recovery
These medications do not restore a cloudy natural lens to transparency.
Experimental cataract treatments include:
- N-acetylcarnosine
- Lanosterol
- VP1-001 and other oxysterols
- Antioxidant compounds
- Protein-aggregation inhibitors
- Novel drug-delivery systems
The current evidence shows:
- N-acetylcarnosine has not demonstrated convincing cataract reversal.
- Lanosterol has produced conflicting laboratory and animal findings.
- VP1-001 has shown effects in selected mouse cataract models.
- No experimental drop has replaced surgery in routine human clinical practice.
Patients should be cautious about products claiming to:
- Dissolve cataracts within weeks
- Cure every cataract type
- Eliminate the need for surgery
- Work because they are natural
- Be clinically proven based only on testimonials
Unapproved eye drops may cause:
- Irritation
- Infection
- Corneal injury
- Vision loss
- Delay in receiving effective treatment
When cataract symptoms remain mild, patients may use:
- Updated spectacles
- Improved lighting
- Magnification
- Sunglasses
- Dry-eye treatment
- Regular monitoring
When cataracts interfere with driving, reading, work, mobility or independence, cataract surgery should be considered.
At present, cataract surgery remains the only established treatment that removes the cloudy natural lens and replaces it with a clear artificial lens.
References
- National Eye Institute. Cataracts. Updated November 2025.
- National Eye Institute. Cataract Surgery. Updated December 2024.
- US Food and Drug Administration. What You Should Know About Eye Drops. Content current June 15, 2026.
- Chen SP, Woreta F, Chang DF. Cataracts: A Review. JAMA. 2025;333:2093–2103. PMID: 40227658.
- Lee BJ, et al. Advances in Drug Therapy and Delivery for Cataract Treatment. 2023. PMID: 36484206.
- De Diego-García L, et al. Pharmacological Strategies for Cataract Management. 2025.
- Wang L, et al. Research Progress on Antioxidants and Protein-Aggregation Inhibitors for Cataract. 2024.
- Dubois VDP, Bastawrous A. N-Acetylcarnosine Drops for Age-Related Cataract. Cochrane Database of Systematic Reviews. 2017. PMID: 28245346.
- Babizhayev MA, et al. Efficacy of N-Acetylcarnosine in the Treatment of Cataracts. 2002. PMID: 12001824.
- Zhao L, et al. Lanosterol Reverses Protein Aggregation in Cataracts. Nature. 2015. PMID: 26200341.
- Daszynski DM, et al. Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity From Cataracts. 2019. PMID: 31186457.
- Zhang K, et al. Inhibitory Effect of Lanosterol on Cataractous Lens of Cynomolgus Monkeys. 2022.
- Molnar KS, et al. Mechanism of Action of VP1-001 in Crystallin-Associated Cataracts. 2019. PMID: 31369034.
- Wang K, et al. Oxysterol Compounds in Mouse Mutant Alpha-A and Alpha-B Crystallin Cataracts. 2022. PMID: 35575904.
- Chen Y, et al. Nanomedicine-Based Drug Delivery for Cataract Treatment. 2024.
- Xu J, et al. Advances in Pharmacotherapy of Cataracts. 2020.
- US Food and Drug Administration. Warning Letter Concerning Unapproved Lanosterol Cataract Products. 2023.
